Strengths

● Its low valuation, with P/E ratio at 5.93 and 6.13 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.2 for the 2022 fiscal year.

● The company has a low valuation given the cash flows generated by its activity.

● The company is one of the best yield companies with high dividend expectations.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's earnings growth outlook lacks momentum and is a weakness.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.